31.03.2011 • News

Finland's Kemira To Waive Tikkurila Stake

Chemicals firm Kemira will sell the rest of the shares it owns in paints firm Tikkurila, its former division, it said on Thursday after market's closing.

Kemira said it will put some 6.2 million shares or 14% of Tikkurila into an accelerated book-built offering, managed by Danske Bank and Deutsche Bank's London branch. Tikkurila shares closed at €16.60 ($23.35), which makes the stake worth €102.5 million.

Through its spin-off from Kemira, Tikkurila became the only company that was listed in Helsinki bourse's main list in 2010.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.